we believe that our vision for Maryland — which includes preserving reproductive rights ... — resonates deeply with voters.
Preserve reproductive rights.
Occurrences
Evidence
On March 12, 2026, Senator Angela Alsobrooks co-sponsored S.1261, the CONNECT for Health Act of 2025, which was read twice and referred to the Committee on Finance.
On April 14, 2025, Senator Angela Alsobrooks released a statement marking Black Maternal Health Week, expressing commitment to ending the maternal health crisis and protecting Black mothers.
On March 25, 2026, Senator Angela Alsobrooks joined leaders from the Black Women’s Roundtable at a press conference at the U.S. Capitol, calling on Congress to protect voting access and economic equity ahead of the 2026 midterm elections.
On July 16, 2025, Senator Angela Alsobrooks introduced the Uterine Fibroid Intervention and Gynecological Health Treatment Act, a bipartisan bill aimed at expanding access to early screenings and treatment for uterine fibroids.
On October 10, 2024, during a debate, Angela Alsobrooks criticized former Governor Larry Hogan for vetoing a 2022 bill that expanded abortion rights in Maryland, highlighting her commitment to reproductive rights.
The June 1-11, 2026 press releases on Alsobrooks's official Senate site cover AI, nominations, conservation, small-business procurement, insulin costs, ICE funding, infrastructure, trucking taxes, and gun violence. I did not find a reproductive-rights-specific release in this lookback window.
The official legislation page lists recent June 2026 sponsored and cosponsored items such as Secure America Act amendments, a gun-violence resolution, and other unrelated bills. No reproductive-rights bill or amendment appears in the visible lookback period.
Alsobrooks's June 15-18, 2026 voting record shows nominations and procedural votes on housing, Iran, and immigration-related motions. The visible record does not show a reproductive-rights vote in the lookback window.
Assessments
Alsobrooks has been in federal office only since January 3, 2025, and the record provided does not show that she delivered a completed federal outcome preserving reproductive rights during this term. The strongest evidence here is campaign-era support for abortion rights and adjacent women’s health activity, but the official Senate-site evidence in the payload does not document a reproductive-rights bill she passed, a decisive vote producing that outcome, or another completed federal protection attributable to her. Because the promise is broad and ongoing, and because the current record shows support without a completed result, this is better scored as unresolved rather than delivered, partial, or never.
There is no direct evidence that Senator Angela Alsobrooks has delivered on the promise to preserve reproductive rights during her current term. Evidence shows statements of support and criticism of opponents, but there are no legislative initiatives or executive actions specifically targeting the preservation or expansion of reproductive rights. Her relevant legislative activities were limited to uterine fibroid treatment and maternal health, not direct reproductive rights preservation.
The evidence shows that Senator Alsobrooks has publicly expressed support for reproductive rights and criticized opponents who oppose such rights. However, there is no evidence of concrete legislative action directly focused on preserving or enhancing reproductive rights (e.g., sponsoring or co-sponsoring relevant bills). The actions cited (statements, debate comments, and legislation related to maternal health and fibroids) do not fulfill the specific promise to preserve reproductive rights. Therefore, the outcome remains unresolved.